Collection of Maternal and NeoNatal Blood to Establish The Ontogeny of Fetal Immunity

Brief description of study

Stem cell biology has emerged as a rapidly developing and controversial field in contemporary medical science. A new era of stem cell therapy has begun with grafting of stem cells from umbilical cord blood for treatment of disease. The traditional bone marrow stem cell grafts may be replaced by a more available and possibly more efficacious source, human umbilical cord blood harvested from placentas after delivery of the infant

Clinical Study Identifier: 10711
Principal Investigator: Bruce K Young.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.